vs
Indivior Pharmaceuticals, Inc.（INDV）与SHOE CARNIVAL INC（SCVL）财务数据对比。点击上方公司名可切换其他公司
Indivior Pharmaceuticals, Inc.的季度营收约是SHOE CARNIVAL INC的1.2倍（$357.0M vs $297.2M），Indivior Pharmaceuticals, Inc.净利率更高（28.9% vs 4.9%，领先23.9%），SHOE CARNIVAL INC自由现金流更多（$19.7M vs $-245.0M）
Indivior是一家全球专科制药企业，专注于开发和商业化针对阿片类物质使用障碍、酒精依赖及相关精神健康疾病的循证治疗方案，核心市场覆盖北美与欧洲，旗下多款获批疗法服务于医疗需求未被充分满足的患者群体。
Shoe Carnival Inc是一家美国家庭鞋类零售商，目前在美国中西部、南部、东南部地区以及波多黎各共开设了429家门店。该公司由大卫·拉塞尔于1978年创立，截至2025年，其总部位于南卡罗来纳州福特米尔。
INDV vs SCVL — 直观对比
营收规模更大
INDV
是对方的1.2倍
$297.2M
净利率更高
INDV
高出23.9%
4.9%
自由现金流更多
SCVL
多$264.7M
$-245.0M
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $357.0M | $297.2M |
| 净利润 | $103.0M | $14.6M |
| 毛利率 | 82.1% | 37.6% |
| 营业利润率 | 22.7% | 6.3% |
| 净利率 | 28.9% | 4.9% |
| 营收同比 | — | -3.2% |
| 净利润同比 | 390.5% | -23.9% |
| 每股收益（稀释后） | $0.79 | $0.53 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INDVSCVL
| Q4 25 | $357.0M | $297.2M | ||
| Q3 25 | $314.0M | $306.4M | ||
| Q2 25 | $302.0M | $277.7M | ||
| Q1 25 | $266.0M | $262.9M | ||
| Q4 24 | — | $306.9M | ||
| Q3 24 | $307.0M | $332.7M | ||
| Q2 24 | $299.0M | $300.4M | ||
| Q1 24 | — | $280.2M |
净利润INDVSCVL
| Q4 25 | $103.0M | $14.6M | ||
| Q3 25 | $42.0M | $19.2M | ||
| Q2 25 | $18.0M | $9.3M | ||
| Q1 25 | $47.0M | $14.7M | ||
| Q4 24 | — | $19.2M | ||
| Q3 24 | $22.0M | $22.6M | ||
| Q2 24 | $-97.0M | $17.3M | ||
| Q1 24 | — | $15.5M |
毛利率INDVSCVL
| Q4 25 | 82.1% | 37.6% | ||
| Q3 25 | 73.2% | 38.8% | ||
| Q2 25 | 82.8% | 34.5% | ||
| Q1 25 | 83.1% | 34.9% | ||
| Q4 24 | — | 36.0% | ||
| Q3 24 | 78.5% | 36.1% | ||
| Q2 24 | 73.6% | 35.6% | ||
| Q1 24 | — | 35.6% |
营业利润率INDVSCVL
| Q4 25 | 22.7% | 6.3% | ||
| Q3 25 | 13.7% | 8.2% | ||
| Q2 25 | 23.8% | 4.3% | ||
| Q1 25 | 24.8% | 5.3% | ||
| Q4 24 | — | 8.0% | ||
| Q3 24 | 11.4% | 9.0% | ||
| Q2 24 | -39.5% | 7.5% | ||
| Q1 24 | — | 7.1% |
净利率INDVSCVL
| Q4 25 | 28.9% | 4.9% | ||
| Q3 25 | 13.4% | 6.3% | ||
| Q2 25 | 6.0% | 3.4% | ||
| Q1 25 | 17.7% | 5.6% | ||
| Q4 24 | — | 6.3% | ||
| Q3 24 | 7.2% | 6.8% | ||
| Q2 24 | -32.4% | 5.8% | ||
| Q1 24 | — | 5.5% |
每股收益（稀释后）INDVSCVL
| Q4 25 | $0.79 | $0.53 | ||
| Q3 25 | $0.33 | $0.70 | ||
| Q2 25 | $0.14 | $0.34 | ||
| Q1 25 | $0.38 | $0.53 | ||
| Q4 24 | — | $0.70 | ||
| Q3 24 | $0.16 | $0.82 | ||
| Q2 24 | $-0.72 | $0.63 | ||
| Q1 24 | — | $0.57 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $195.0M | $107.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-98.0M | $683.2M |
| 总资产 | $1.2B | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资INDVSCVL
| Q4 25 | $195.0M | $107.7M | ||
| Q3 25 | $445.0M | $91.9M | ||
| Q2 25 | $510.0M | $93.0M | ||
| Q1 25 | $373.0M | $123.1M | ||
| Q4 24 | — | $91.1M | ||
| Q3 24 | — | $84.5M | ||
| Q2 24 | — | $69.5M | ||
| Q1 24 | — | $111.2M |
股东权益INDVSCVL
| Q4 25 | $-98.0M | $683.2M | ||
| Q3 25 | $-207.0M | $670.7M | ||
| Q2 25 | $-257.0M | $653.6M | ||
| Q1 25 | $-285.0M | $649.0M | ||
| Q4 24 | — | $635.7M | ||
| Q3 24 | $-310.0M | $618.5M | ||
| Q2 24 | $-281.0M | $597.8M | ||
| Q1 24 | — | $583.4M |
总资产INDVSCVL
| Q4 25 | $1.2B | $1.2B | ||
| Q3 25 | $1.4B | $1.2B | ||
| Q2 25 | $1.5B | $1.1B | ||
| Q1 25 | $1.4B | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $1.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-221.0M | $33.6M |
| 自由现金流经营现金流 - 资本支出 | $-245.0M | $19.7M |
| 自由现金流率自由现金流/营收 | -68.6% | 6.6% |
| 资本支出强度资本支出/营收 | 6.7% | 4.7% |
| 现金转化率经营现金流/净利润 | -2.15× | 2.30× |
| 过去12个月自由现金流最近4个季度 | $-93.0M | $35.1M |
8季度趋势，按日历期对齐
经营现金流INDVSCVL
| Q4 25 | $-221.0M | $33.6M | ||
| Q3 25 | $-39.0M | $13.3M | ||
| Q2 25 | $158.0M | $-9.6M | ||
| Q1 25 | $75.0M | $44.5M | ||
| Q4 24 | — | $17.3M | ||
| Q3 24 | $2.0M | $23.7M | ||
| Q2 24 | $88.0M | $17.1M | ||
| Q1 24 | — | $53.4M |
自由现金流INDVSCVL
| Q4 25 | $-245.0M | $19.7M | ||
| Q3 25 | $-59.0M | $2.2M | ||
| Q2 25 | $141.0M | $-23.0M | ||
| Q1 25 | $70.0M | $36.2M | ||
| Q4 24 | — | $8.3M | ||
| Q3 24 | $-5.0M | $18.2M | ||
| Q2 24 | $84.0M | $6.9M | ||
| Q1 24 | — | $40.7M |
自由现金流率INDVSCVL
| Q4 25 | -68.6% | 6.6% | ||
| Q3 25 | -18.8% | 0.7% | ||
| Q2 25 | 46.7% | -8.3% | ||
| Q1 25 | 26.3% | 13.8% | ||
| Q4 24 | — | 2.7% | ||
| Q3 24 | -1.6% | 5.5% | ||
| Q2 24 | 28.1% | 2.3% | ||
| Q1 24 | — | 14.5% |
资本支出强度INDVSCVL
| Q4 25 | 6.7% | 4.7% | ||
| Q3 25 | 6.4% | 3.6% | ||
| Q2 25 | 5.6% | 4.8% | ||
| Q1 25 | 1.9% | 3.2% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | 2.3% | 1.7% | ||
| Q2 24 | 1.3% | 3.4% | ||
| Q1 24 | — | 4.5% |
现金转化率INDVSCVL
| Q4 25 | -2.15× | 2.30× | ||
| Q3 25 | -0.93× | 0.69× | ||
| Q2 25 | 8.78× | -1.03× | ||
| Q1 25 | 1.60× | 3.04× | ||
| Q4 24 | — | 0.90× | ||
| Q3 24 | 0.09× | 1.05× | ||
| Q2 24 | — | 0.99× | ||
| Q1 24 | — | 3.44× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INDV
| Sublocade | $233.0M | 65% |
| Sublingual And Other | $69.0M | 19% |
| Other | $49.0M | 14% |
| Perseris | $6.0M | 2% |
SCVL
暂无分部数据
